Study guide

6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

Key Takeaways Explain This Topic AI

Oxytocin reaches steady-state plasma concentration 30 to 40 minutes after a rate change, so titration intervals are set at 15 to 40 minutes.

Target uterine activity is 3 to 5 contractions per 10 minutes lasting 45 to 60 seconds with palpable relaxation, corresponding to 200 to 250 Montevideo units.

Oxytocin shares homology with vasopressin, so high doses with hypotonic fluid can cause water intoxication, hyponatremia, seizures, and death; it must be mixed in isotonic solution and never given as an undiluted bolus.

If oxytocin was stopped for less than 20 to 30 minutes, restart at half the prior rate; if stopped for 30 to 40 minutes or more, restart at the initial dose.

Amniotomy requires a longitudinal lie, a cephalic presentation engaged at station 0 or lower, and exclusion of vasa previa, followed by 60 seconds of continuous fetal heart rate assessment.

Last updated: September 2026

Oxytocin Infusion Protocols & Titration

Synthetic oxytocin (Pitocin) is identical to the octapeptide hormone synthesized in the supraoptic and paraventricular nuclei of the hypothalamus and secreted by the posterior pituitary. Oxytocin binds to specific G-protein-coupled myometrial receptors, activating phospholipase C to produce inositol trisphosphate (IP3) and diacylglycerol (DAG), which mobilizes calcium from the sarcoplasmic reticulum and stimulates calcium-calmodulin phosphorylation of myosin light-chain kinase, producing myometrial contractions.

Pharmacokinetics

Onset of Action: Intravenous onset is immediate (< 1 minute).

Half-Life: 3 to 5 minutes.

Steady-State Plasma Concentration: Achieved within 30 to 40 minutes of initiating or changing the infusion rate.

Administration & Titration Regimens

Oxytocin must always be administered as a secondary "piggyback" infusion connected to the primary intravenous line at the lowest, most proximal port to ensure immediate cessation if an emergency arises.

Regimen Starting Dose Increment Titration Interval Clinical Characteristics

Low-Dose Regimen 0.5 to 2 mU/min 1 to 2 mU/min Every 15 to 40 minutes Lower rates of uterine tachysystole and FHR decelerations; longer labor duration

High-Dose Regimen 4 to 6 mU/min 4 to 6 mU/min Every 15 to 30 minutes Shortens labor duration and reduces operative vaginal delivery; higher rate of tachysystole

Titration Goals & Clinical Endpoints

Target Contraction Pattern: 3 to 5 contractions per 10 minutes (averaged over 30 minutes), each lasting 45 to 60 seconds , with palpable relaxation (soft tone, < 20 mmHg) between contractions.

Intrauterine Pressure Catheter (IUPC) Target: 200 to 250 Montevideo Units (MVUs) in active labor. (MVUs are calculated by summing the peak contraction amplitudes above resting baseline for all contractions within a 10-minute window).

Maintenance: Once an adequate contraction pattern and steady progressive cervical dilation are established, the oxytocin dose should remain constant or be titrated downward, especially in multiparous women.

Adverse Effects & Toxicity

Uterine Tachysystole & Fetal Hypoxemia: The most common adverse effect, resulting in impaired intervillous blood flow.

Water Intoxication (Hyponatremia): Oxytocin shares structural homology with antidiuretic hormone (arginine vasopressin). High doses (≥ 20 to 40 mU/min) administered over prolonged periods with hypotonic intravenous crystalloids (e.g., 5% Dextrose in Water) can cause severe water retention, profound hyponatremia, cerebral edema, seizures, coma, and maternal death. Oxytocin should always be mixed in isotonic solutions (Normal Saline or Lactated Ringer's).

Hypotension & Tachycardia: Rapid intravenous bolus of undiluted oxytocin produces direct relaxation of vascular smooth muscle, causing profound systemic hypotension, reflex tachycardia, and myocardial ischemia. Oxytocin must never be administered as an undiluted IV bolus.

Uterine Tachysystole: Definition & Management Algorithm

Uterine tachysystole is defined as more than 5 contractions in 10 minutes, averaged over a 30-minute window . It can occur in spontaneous or induced/augmented labor. The historical terms "hyperstimulation" and "hypertonus" have been abandoned by NICHD and ACOG.

  • Stepwise Management of Tachysystole [ Uterine Tachysystole Detected ]
  • (>5 contractions / 10 min over 30 min)
  • │
  • Assess Fetal Heart Rate Tracing
  • │
  • ┌─────────────────────────┴─────────────────────────┐
  • ▼ ▼
  • [ Category I (Normal) FHR ] [ Category II or III FHR ]
  • │ │
  • Reposition to Lateral Decubitus • IMMEDIATELY DISCONTINUE OXYTOCIN
  • Reduce Oxytocin rate by 50% (or remove Cervidil insert)
  • If unresolved after 10-15 min, • Reposition to Lateral Decubitus
  • DISCONTINUE Oxytocin completely • IV Fluid Bolus: 500 mL Lactated Ringer's
  • Supplemental O2 (10 L/min via NRB)
  • if hypoxia or uncorrected
  • If tachysystole & decels persist
  • > 2-3 min: Terbutaline 0.25 mg SQ
  • Tocolytic Pharmacotherapy

Terbutaline: A beta-2 adrenergic agonist administered as a single 0.25-mg dose subcutaneously . It relaxes myometrial smooth muscle within 2 to 3 minutes, halting excessive contractions and restoring intervillous perfusion.

Maternal Side Effects: Transient tachycardia, palpitations, tremor, and hyperglycemia. Terbutaline should not be given if maternal heart rate exceeds 120–130 bpm.

Resuming Oxytocin Following Tachysystole

If oxytocin was discontinued for < 20 to 30 minutes , resume infusion at half the rate that provoked tachysystole once normal FHR and uterine activity have been restored for at least 15 to 30 minutes.

If oxytocin was discontinued for ≥ 30 to 40 minutes , restart at the initial starting dose (e.g., 1 to 2 mU/min).

Amniotomy (Artificial Rupture of Membranes / AROM)

Amniotomy is the deliberate artificial rupture of the amniotic sac using an amnihook. It is performed to induce or augment labor, accelerate active-phase progress, or allow placement of internal monitors (fetal scalp electrode [FSE] or intrauterine pressure catheter [IUPC]).

Prerequisites & Safety Check

Vertex Presentation: Fetal lie must be longitudinal and presentation must be cephalic.

Engagement of the Presenting Part: The fetal vertex MUST be well-engaged against the cervix (station 0 or lower) . Performing amniotomy with a high, floating, or unengaged presenting part (negative station) creates a dangerous fluid rush that can sweep the umbilical cord downward through the cervix, precipitating a catastrophic umbilical cord prolapse .

Absence of Vasa Previa: Ensure no aberrant fetal vessels traverse the internal os.

Technique & Immediate Post-AROM Protocol

Perform sterile vaginal examination to assess cervical dilation, effacement, station, and exclude cord presentation.

Guide the plastic amnihook between the index and middle fingers, securing the hook against the forewaters during or between contractions; gently snag and tear the membrane.

Keep fingers in the vagina during the fluid rush to maintain the vertex against the cervix and immediately palpate for any prolapsed umbilical cord loops.

IMMEDIATE FHR AUSCULTATION: Auscultate or visualize the fetal heart rate continuously for a full 60 seconds immediately following AROM to detect acute bradycardia or severe variable decelerations indicative of occult or overt cord compression.

Documentation: Document fluid characteristics: color ( clear , light meconium , thick meconium , or frank blood ), odor, and estimated volume.